live In the news:
T'gana pharma biggies to inject 5,200cr in Pharma City, create over 12,000 jobs - Pharma shares hit as Trump picks RFK Jr to lead health department - What the NFL Draft Can Teach Investors About Big Pharma - A stronger Ozempic, Wegovy sales boom, and Hims' generic weight loss drug: Pharma news roundup - 'Pharma City to be ready for units to set up shop in 1 year' - Pharma's race for obesity drugs is still hotting up - Pharma and agritech groups push against biodiversity levy at UN summit - Ozempic and Alzheimer's, 23andMe's crisis, and Novo Nordisk wants a crackdown: Pharma news roundup - 2 held for kidnapping pharma staff in Chennai - Next-gen weight loss drugs will have fewer side effects than Ozempic, pharma CEO says

Pharmadar

1 day ago
bookmarkSave

Key facts

Classified as: organization

Summary

Pharmadar is a company. It was founded in 2013. The company is part of the Health Care sector, specifically in the Pharmaceuticals industry.

Business

  • Employees: get premium Premium to see estimate
  • Revenues: get premium Premium to see estimate

Stocks from Pharmadar

Explore more on business

Talking Points:

Learn more about talking points

In literature

There is no book written about Pharmadar in the database

Related

Connected or similar:

Details

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter

This content can be used under the CC BY 4.0 license